Ejaz Pathan
Overview
Explore the profile of Ejaz Pathan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
277
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Biallas R, Dean L, Davidson L, Hollick R, Pathan E, Robertson L, et al.
Arthritis Care Res (Hoboken)
. 2020 Nov;
74(4):665-674.
PMID: 33140891
Objective: To determine among patients with axial spondyloarthritis (SpA) the factors associated with decreased spinal mobility and to determine whether poor mobility is a predictor of response to anti-tumor necrosis...
2.
Jones G, Dean L, Pathan E, Hollick R, Macfarlane G
Ann Rheum Dis
. 2020 Apr;
79(7):914-919.
PMID: 32327428
Management guidelines assume that results from clinical trials can be generalised, although seldom is data available to test this assumption. We aimed to determine the proportion of patients commencing tumour...
3.
Nakamura A, Talukdar A, Nakamura S, Pathan E, Haroon N
Best Pract Res Clin Rheumatol
. 2020 Apr;
33(6):101491.
PMID: 32305314
Axial spondyloarthritis (SpA) is a chronic disease characterised by new bone formation (NBF) in the axial skeleton as well as at peripheral entheseal sites. NBF is thought to arise in...
4.
Macfarlane G, Pathan E, Jones G, Dean L
Rheumatology (Oxford)
. 2020 Jan;
59(9):2481-2490.
PMID: 31990352
Objectives: While many axSpA patients, eligible to receive anti-TNFα therapy, derive benefit when prescribed them, some patients do not. The current study aims to identify modifiable targets to improve outcome...
5.
Macfarlane G, Rotariu O, Jones G, Pathan E, Dean L
Ann Rheum Dis
. 2019 Oct;
79(2):202-208.
PMID: 31662321
Objective: To determine modifiable factors associated with poor quality of life (QoL) in patients with axial spondyloarthritis (axSpA). Methods: Analysis of data from the British Society for Rheumatology Biologics Register...
6.
Macfarlane G, Pathan E, Siebert S, Packham J, Gaffney K, Choy E, et al.
BMC Rheumatol
. 2019 May;
3:19.
PMID: 31143851
Background: Around 1 in 8 patients with axial spondyloarthritis (axSpA) also meet criteria for fibromyalgia and such patients have considerable unmet need. Identifying effective therapy is important but to what...
7.
Abbood H, Pathan E, Cherukara G
J Appl Oral Sci
. 2018 Nov;
27:e20180207.
PMID: 30427476
Objective: The aim of this study is to investigate the association between AS and oral conditions. Material And Methods: This research was conducted using the UK Biobank Resource under Application...
8.
Macfarlane G, Shim J, Jones G, Walker-Bone K, Pathan E, Dean L
J Rheumatol
. 2018 Nov;
46(2):145-152.
PMID: 30385702
Objective: First, to test the hypothesis that, among working patients with axial spondyloarthritis (axSpA), those who report issues with reduced productivity at work (presenteeism) are at higher risk of work...
9.
Macfarlane G, MacDonald R, Pathan E, Siebert S, Gaffney K, Choy E, et al.
Rheumatology (Oxford)
. 2018 Jul;
57(11):1982-1990.
PMID: 30053166
Objective: To quantify the extent to which co-morbid FM is associated with higher disease activity, worse quality of life (QoL) and poorer response to TNF inhibitors (TNFis) in patients with...
10.
Macfarlane T, Abbood H, Pathan E, Gordon K, Hinz J, Macfarlane G
Eur J Rheumatol
. 2018 Apr;
5(1):45-52.
PMID: 29657875
The question of whether diet plays a role in the onset of ankylosing spondylitis (AS) or can affect the course of the disease is an important one for many patients...